"Rush's neurology and neurosurgery program is ranked No. 3 in the country by U.S. News & World Report."

During the past decade, Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755" #1 sponsor was "Ipsen" with 1 trials, followed by "Massachusetts General Hospital" with 1 trials sponsored, "Novartis" with 1 trials sponsored, "University of Rochester" with 1 trials sponsored and "Weill Medical College of Cornell University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator and "University of Rochester" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755" are "Cervical Dystonia" (1 trials), "Huntington's Disease" (1 trials), "Multiple Sclerosis" (1 trials), "Parkinson Disease" (1 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755" in a lesser frequency.

Most popular intervention types in "Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "Coenzyme Q10 with vitamin E" (1 trials), "Fingolimod" (1 trials), "Placebo" (1 trials) and "coenzyme Q10" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rush University Medical Center Department of Neurological Sciences, 1725 West Harrison Suite 755, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".